Kolon Biotech provides CDMO services fully engaged in cell & gene therapy that enable successful development of biological therapeutics.
Our CDMO service fulfills the established project objectives and works towards the satisfaction of clients. Also, we meet the demands for manufacturing capacity and flexibility by using a manufacturing platform named SACS (Semi-Automated & Closed System) in a cGMP compliant facility.
We provide end-to-end CDMO service or each service chosen by clients for what they need (e.g. Process development, Production, QC test, etc.).
Company Details
- Employees
- 7
- Founded
- 2020
- Address
- 54-1, Gieopdosi 1-Ro, Daesowon-Myeon, Chungju,chungcheongbuk-Do 27465,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://kolonbiotech.co.kr
- Keywords
- Cell and gene therapy, GMP Manufacturing, Quality Assurance, Quality Control, Regulatory Affair, Process Development, Technology Transfer, Exosome, End-to-end Service, Project Management, Bio.
- HQ
- Chungju, Chungcheongbuk-do
Kolon Biotech, Inc. Questions
Kolon Biotech, Inc.'s website is http://kolonbiotech.co.kr
Kolon Biotech, Inc.'s LinkedIn profile is https://kr.linkedin.com/company/kolonbiotech
Kolon Biotech, Inc. has
7 employees.
View email and phone details for 7
employees at Kolon Biotech, Inc..
Kolon Biotech, Inc.'s industry is
Biotechnology Research
Kolon Biotech, Inc.'s top competitors are
Merck Life Science,
Pboa - Pharma & Biopharma Outsourcing Association,
Psci - Pharmaceutical Supply Chain Initiative,
Kolon Life Science, Inc. (코오롱생명과학),
Almac Group,
Pharmasource,
Flamma Group,
Onyx Scientific,
Terumo Pharmaceutical Solutions Division,
Kolon Tissuegene, Inc..
Kolon Biotech, Inc.'s categories are Biotechnology Research
Kolon Biotech, Inc.'s founding year is 2020
